Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Virtual Preceptorship on GEP and Lung NENs 2021

Session 2 Current State of the Art on GEP NENs - Part 2

Eligibility Criteria for Peptide Receptor Radionuclide Therapy (PRRT) and Indications in GEP NET Patients

Date

21 Jun 2021

Session

Session 2 Current State of the Art on GEP NENs - Part 2

Topics

Tumour Site

Neuroendocrine Neoplasms;  Gastrointestinal Cancers

Presenters

G. Nicolas, CH

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Chemotherapy in GEP NENs

Presenter: J. Valle, UK

Session: Session 2 Current State of the Art on GEP NENs - Part 2

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.